June 2014

Recent News Clips

06/02/2014 Clinical trial analysis suggests drug combination may be highly effective in recurrent ovarian cancer Trial results showed a near doubling of the length of time during and after treatment that the cancer did not get worse.

5/22/2014 Inclusion Reporting Expands to Progress Reports There is an updated format for providing sex/gender, race, and ethnicity information in progress reports for clinical research studies.

5/19/2014 Personalized Immunotherapy Treats Epithelial Cancer from NIH Research Matters - A new treatment uses a patient's own immune system to attack tumor cells. The approach may be used to treat many common cancers.

5/14/2014 NIH Takes Steps to Address Sex Differences in Preclinical Research  NIH steps to address sex differences in preclinical research.

NCI Standard Funding Opportunity Announcements

Current and Recent Program Announcements  |  Current and Recent Requests for Applications
Current and Recent NCI and Trans-NIH Initiatives | Requests for Proposals  |  Standard Due Dates

June 10 (Pre-app) Jr. Faculty Federal Career Development

Peer Reviewed Cancer Research Program (PRCRP)
Career Development Award

Supports impactful research projects with an emphasis on discovery.
Due Date June 10 - Pre-applications
Invited Applications:
September 18 (OSR)  |  September 22 (Sponsor)
Amount & Project Period: $360,000 (Direct Costs) -  3 years
Eligibility: Applicants must be within 7 years of first faculty appointment and have a minimum of 30% protected time for proposed research.
Contact: Linda Nolan, x6071
RFA Link: W81XWH-14-PRCRP-CDA
 
June 10 (Pre-app) Jr. Faculty Federal Special Focus Ideas
 

PRCRP Idea Award with Special Focus

To be considered for funding, applications for the PRCRP Idea Award with Special Focus must address at least one of the Topic Areas as directed by Congress. Research applications in the areas of breast, prostate, lung (excluding mesothelioma), or ovarian cancer will not be accepted.
Due Date June 10: Pre-applications
Invited Applications:
September 15 (OSR)  |  September 17 (Sponsor)
Amount & Project Period: $300,000 direct costs over 2 years
Eligibility: Jr. Faculty at or above Assistant Professor
Contact: Linda Nolan, x6071
RFA Link: W81XWH-14-PRCRP-IA

New
June 12 (Pre-app) All Faculty Federal Prostate Cancer

Prostate Cancer Research Program (PCRP)
Synergistic Idea Development Award

Supports new ideas representing innovative approaches to prostate cancer research involving 2 or 3 independent, faculty-level (or equivalent) PIs utilizing their complementary and synergistic perspectives to address a central problem or question in prostate cancer research. Designed to support new and pre-existing partnerships
Due Date June 12 (Pre-application)
Invited Applications:
September 22 (OSR)  |    September 24 (Sponsor)

Amount & Project Period: $750,000 (Direct Costs) - 3 years

Eligibility: At or above Assistant Professor
 
Contact: Linda Nolan (x6071)

RFA Link: W81XWH-14-PCRP-SIDA
New
June 12 (Pre-app) All Faculty Federal Prostate

Prostate Cancer Research Program (PCRP)
Idea Development Award

Supports new ideas representing innovative approaches to prostate cancer research Presentation of preliminary data is encouraged but not required.
Due Date June 18 (Pre-application) 
Invited Applications
September 22 (OSR)  |  September 24 (Sponsor)
Amount & Project Period: 3 year performance period
Established Investigators: $375,000 (Direct Costs)
New Investigators: $225,000 (Direct Costs)
Eligibility: All Faculty
Contact: Linda Nolan (x6071)
RFA Link: W81XWH-14-PCRP-IDA
June 12 (OSR)
June 16 (Sponsor)
Grad students/Postdocs/
Fellows/Med Students/Nurse Researchers
Non-federal Lung Cancer

Lung Cancer Research Foundation Award

The Lung Cancer Research Foundation welcomes submissions of grant requests for medical/scientific research projects covering all aspects of lung cancer research. Grant requests can include new project submissions, as well as requests for renewal of current funding.
Due Date June 12 - OSR June 16 - Sponsor
Amount & Project Period: $50,000 - 1 year
Eligibility: Graduate Students, postdoctoral researchers, physicians, medical students, & nurse researchers
Contact: Linda Nolan, x6071
RFA Link: LCRF 2014 Grants
 
 June 11 (OSR)
June 13 (Sponsor)
All Faculty Non-federal Disparities Research

The A. David Mazzone Research Awards Program
Disparity Research Awards

To address prostate cancer disparities as differences in the incidence, prevalence, mortality, and burden of prostate cancer and related adverse health conditions on specific population groups Focus on factors that contribute to prostate cancer disparities including interactions of the social and physical environment, behavioral factors, and/or biologic/molecular pathways.
Due Date: June 11 (OSR)  |  June 13 (Sponsor)
Amount & Project Period:
$35,000/year (Direct Costs) - 2 years
Eligibility:
Two or more independent investigators, at least one of whom holds a full-time Harvard faculty appointment at the level of Instructor or higher.
Contact:
Linda Nolan, x6071
RFA Link: Disparity Research Award
June 16 (LOI) HOPA Members Non-federal Hematology/Oncology

The Hematology/Oncology Pharmacy Association (HOPA) Foundation 2014 Research Fund Award

To facilitate the efforts of hematology/oncology pharmacists working to optimize the care of individuals affected by cancer.
Due Date June 16 - Letter of Intent Invited Applications:
September 11 (OSR)  |  September 15 (Sponsor)
Amount & Project Period: $50,000 total for 1 year
Eligibility: HOPA  Members only
Contact: Linda Nolan, x6071
RFA Link: 2014 HOPA Research Fund Award
June 18 (Pre-app.) All Faculty Federal Biomarker Development

Prostate Cancer Research Program (PCRP)
Biomarker Development Award

High-impact research aimed at multi-institutional validation and/or qualification of prostate cancer biomarkers for crucial decision making in prostate cancer management, including detection of aggressive disease, prognosis and progression, and prediction and assessment of response to therapy.
 
Due Date June 18 (Pre-application) Invited Applications:
September 22 (OSR) |  September 24 (Sponsor)
Amount & Project Period: $2,250,000 (Direct Costs) - 3 years
Eligibility: Applications are required to be multi-institutional in  approaches to large-scale biomarker validation or qualification.
Each PI (Initiating and Partnering) must be at or above Assistant Professor.
 
Contact: Linda Nolan (X6071)
 
RFA Link: W81XWH-14-PCRP-BDA
U01 NIH
June 17 - OSR
June 19 - Sponsor
All Faculty Federal Big Data

Development of Software and Analysis Methods for Biomedical Big Data in Targeted Areas of High Need 

Development of innovative analytical methods and software tools with the objective of addressing current & emerging needs for using, managing, and analyzing the larger and more complex data sets inherent to biomedical Big Data. FOA has 4 focus areas: Data Compression/Reduction, Data Visualization, Data Provenance & Data Wrangling.
Due Date: June 17 (OSR)  |  June 19 (Sponsor)
Amount & Project Period: $300,000/year (Direct Costs) - 3 years
Eligibility: All Faculty
Contact: Linda Nolan, x6071
RFA Link: RFA-HG-14-020


New
June 20 (LOI) All Ranks Federal PCOR

Disseminating and Implementing Evidence from Patient-Centered Outcomes Research in Clinical Practice Using Mobile Health Technology (R21)

To develop and evaluate the effectiveness of novel approaches that use mHealth tools to enable timely incorporation and appropriate use of PCOR evidence in clinical practice
Due Date June 20 (Letter of Intent)
Applications Due:
July 31 (OSR)  |  August 4 (Sponsor)
Amount & Project Period: $300,000 (TOTAL COSTS) - 2 years
Eligibility: All Ranks - PD/PI expected to contribute a minimum of 15% annual effort each year of grant. Only one PD/PI may be designated on the application.
Contact: Linda Nolan (X6071)
RFA Link: RFA-HS-14-010
R01/R21 NIH
June 18 - OSR
June 20 - Sponsor
All Faculty Federal Provocative Cancer Questions

Research Answers to NCI's Provocative Questions

Innovative research projects designed to solve specific problems and paradoxes in cancer research. This is the final submission date for these RFAs.
Due Date: June 18 (OSR)  |  June 20 (Sponsor)
Amount & Project Period: R01 - Unlimited funding - 4 years
R21 - $275,000 (Direct Costs) - 2 years
Eligibility: All Faculty
Contact: Linda Nolan, x6071
RFA Links and related topics for all groups: Group A - relates to investigation of changes in behavior & exposure risks, mechanistic links between cancer risk factors and biological events associated with cancer development.
RFA-CA-13-016 (R01)  |  RFA-CA-13-017 (R21)

Group B - Relates to mechanisms of tumor development or recurrence.
RFA-CA-13-018 (R01)  |  RFA-CA-13-019 (R21)

Group C - Relates to cancer detection, diagnosis, and prognosis. RFA-CA-13-020 (R01)  |  RFA-CA-13-021 (R21)

Group D - Relates to cancer therapy.
RFA-CA-13-022 (R01)  |  RFA-CA-13-023 (R21)

Group E - Relates to clinical effectiveness.
RFA-CA-13-024 (R01)  |  RFA-CA-13-025 (R21)


New
June 25 All Ranks Federal Prostate

Prostate Cancer Research Program Exploration Hypothesis Development Award

Supports the exploration of highly innovative, untested, potentially high-gain concepts, theories, paradigms, and/or methods that address an important problem in prostate cancer. Presentation of preliminary data is inconsistent with the intent of this award mechanism and is therefore strongly discouraged. However, logical reasoning and a sound scientific rationale for the proposed work must be described.
 
Due Date: June 25 (Pre-application)
July 7 (OSR) | July 09 (Sponsor)
Amount & Project Period: $75,000 (direct Costs) - 1 year
Eligibility: All investigators at or above postdoctoral fellow (or equivalent) are eligible.
Contact: Linda Nolan (X6071)
RFA Link: W81XWH-14-PCRP-EHDA
June 27 (LOI) All Faculty Non-Federal PCO Evaluations

Large Pragmatic Studies to Evaluate Patient-Centered Outcomes

Eligible studies compare two or more alternatives for addressing prevention, diagnosis, treatment, or management of a disease or symptom; improving health care system-level approaches to managing care; or eliminating health or healthcare disparities.
Due Date: June 27 - Letter of Intent
Invited Applications:

October 31 (OSR)  |  November 4 (Sponsor)
Amount & Project Period: $10,000,000 direct costs over 5 years
Eligibility: All Faculty
Contact: Linda Nolan, x6071
PA Links: Announcement  |  Funding Center


New
June 29 (LOI) All Ranks Federal Disparities Research

NLM Information Resource Grants to Reduce Health Disparities (G08)

Projects that will bring useful, usable health information to health disparity populations and their health care providers. A G08 grant is available to health-related institutions to improve the organization and management of health related information using computers and networks.

Due Date June 29 (Letter of Intent)
Applications Due:
July 25 (OSR)  |  July 29 (Sponsor)
Amount & Project Period: $100,000 - 1 year,
$200,000 - 2 years or
$300,000 - 3 years
No F&A allowed  
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-LM-14-001
June 26 (OSR)
June 30 (Sponsor)
MD, PhD or MD/PhD Non-Federal Leukemia

Children's Leukemia Research Association, Inc.

Seeks to fund research grants for doctors who are conducting the most promising research into leukemia, in the hopes of isolating the causes and finding a cure for this dread disease.
Due Date October 31 - (OSR)  |  November 4  - (Sponsor)
Amount & Project Period: $30,000 total for 1 year
Eligibility: MDs, PhDs or MD/PhDs conducting leukemia research.
Contact: Linda Nolan, x6071
RFA Link: CLRA Research Grants
June 26 (OSR)
June 30 (Sponsor)
Clinical Faculty Non-federal Nintedanib

Phase I/II Clinical Trials and Correlative Studies of Nintedanib for Selected Solid Tumors

Proposed clinical trials should focus on developing feasible studies of Nintedanib with particular emphasis on lung and gastrointestinal cancers. Clinical trials in other areas will be considered if supported by a strong mechanistic rationale.
Due Date June 26 (OSR)  |  June 30 (Sponsor)
Amount & Project Period: 2 years Phase I and Single-arm, Phase II clinical trials: $300,000 (total costs include direct costs and 25% indirect costs) per trial.
The Correlative Laboratory studies section
of the clinical trial will be funded up to a total cost of $100,000, including up to 25% indirect costs
Eligibility: Clinical Faculty
Contact: Linda Nolan (X6071)
RFA Link: Phase I/II Clinical Trials and Correlative Trials of Nintedanib for Selected Solid Tumors
U01 NIH

New
June 26 (OSR)
June 29 (Sponsor)
All Ranks Federal Mathematical Modeling

Development of an Integrated Mathematical Model for Comparative Characterization of Complex Molecules

A mathematical algorithm or model, integrating in vitro chemical and biological characterization data based on an orthogonal set of high-resolution characterization methods will be developed to provide a coherent picture of the structure for the complex molecules
Due Date June 26 (OSR) │ June 29 (Sponsor)
Amount & Project Period: $600,000 (Total Costs) - 1 year
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-FD-14-082


New
June 27 (OSR)
July 1 (Sponsor)
Jr. Faculty
Clinical Fellows
Non-Federal Basic or Trans/Clin Res

Damon Runyon-Rachleff Innovation Award

Specifically designed to provide funding to extraordinary early career researchers with an innovative new idea but without sufficient preliminary data to obtain traditional funding. Research must be novel and have strong potential for high impact in the cancer field.
Due Date June 27 - OSR  |  July 1 - Sponsor
Amount & Project Period: $150,000/year for 3 years
Eligibility: Applicants must belong to one of the following categories:
1.  Tenure-track Assistant Professors within 4 years of  initial Assistant Professor position. (Cut-off date: July 1, 2010.)
2.  Clinical Instructors and Senior Clinical Fellows (in final year of sub-specialty training) holding MD and pursuing a period of independent research before taking a tenure-track faculty position.  Must have an exceptional record of research accomplishment, dedicated laboratory space and the support of institution.
3.  Must have 80% protected time for research
4.  Non-citizens may apply
Contact: Linda Nolan, x6071
Links: Innovation Award Overview  |  Application Guidelines
June 27 (OSR)
July 1 (Sponsor)
Postdocs Non-Federal Biomedical Science

The Helen Hay Whitney Foundation

Supports early postdoctoral research training in all basic biomedical sciences.
Due Date June 27 - OSR  |  July 1 - Sponsor
Amount & Project Period: Year 1 - $49,000
Year 2 - $50,000
Year 3 - $51,000
Eligibility: US citizen postdocs with no more than 1 year training at time of application.
Contact: Linda Nolan, x6071
Link: HHWF Postdoctoral Fellowship

in collaboration
with the Marcus
Foundation


New
June 30 (LOI) All Faculty Non-federal Prostate Cancer

Intravenous Vitamin C Therapy for Prostate Cancer Patients

Pilot award for a project that will investigate the mechanisms and potential for intravenous vitamin C therapy in the treatment of advanced prostate cancer and mitigation of chemotherapy associated toxicity.
Due Date June 30 (Letter of Intent)
Amount & Project Period: $100,000 - 1 year
Eligibility: All Faculty
Contact: Linda Nolan (X6071)
Letter of Intent Submission information: Please submit a 2-page LOI that contains:
• Research Strategy and Objectives;
• Impact; and
• Personnel

The LOI should include your name, email address and phone number at top of first page. Please email a PDF of the LOI to applications@pcf.org. A select number of applicants will be invited by PCF to submit full five-page applications for this award.


New
June 30 All Ranks Non-federal Nintedanib

National Comprehensive Cancer Network (NCCN)
Phase I/II Clinical Trials and Correlative Trials of Nintedanib for Selected Solid Tumors

Proposed clinical trials should focus on developing feasible studies of nintedanib w/a particular emphasis on lung and gastrointestinal (including gastric, pancreatic, neuroendocrine and colorectal) cancers. Clinical trials in other areas will be considered if supported by a strong mechanistic rationale.
Due Date June 26 (OSR)  |  June 30 (Sponsor)
Amount & Project Period: 2 years
Phase I and Single-arm, Phase II clinical trials: $300,000 (total costs including direct costs and 25% indirect costs) per trial. The Correlative Laboratory studies section of the clinical trial will be funded up to a total cost of $100,000, including up to 25% indirect costs
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: Phase I/II Clinical Trials and Correlative Trials of Nintedanib for Selected Solid Tumors
U01 NCI
June 8 (LOI)
July 3 (OSR)
July 8 (Sponsor)
All Faculty Federal Cancer Epidemiology

Core Infrastructure & Methodological Research for Cancer Epi Cohorts

 Support for infrastructure and core functions for existing or new Cancer Epidemiology Cohorts (CECs).
 
Due Date June 8 - Letter of intent
Applications Due:

July 3 - OSR  |   July 8 - Sponsor

Amount & Project Period: Budget not limited for 5 years
Eligibility: All Faculty
Contact: Linda Nolan, x6071
RFA Link: PAR-14-160


New (4)
July 10 (Pre-app.) All Ranks Federal Neurofibromatosis

Neurofibromatosis Research Program (NFRP)
New Investigator Award

Supports development of independent investigators and/or transition of established investigators into a career in NF research. Experience in NF research not required. Preliminary or published data required Clinical trials not allowed.
Due Date (All NFRP Initiatives below) July 10 (Pre-application)
Applications Due:
July 22 (OSR)  |  July 24 (Sponsor)
Amount & Project Period: $400,000 (Direct Costs) - 4 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
PA Link: W81XWH-14-NFRP-NIA

Neurofibromatosis Research Program (NFRP)
Investigator-initiated Research Award

Supports highly rigorous, high-impact research with potential to make an important contribution to NF research and/or patient care. Preliminary or published data required. Optional Qualified Collaborator:  Applications that include a Qualified Collaborator meeting criteria identified in the Program Announcement may apply for a higher level of funding. Clinical trials not allowed.
Amount & Project Period: $525,000 (Direct Costs)
$575,000 if incl. Optional Qualified Collaborator - 3 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
PA Link: W81XWH-14-NFRP-IIRA

Neurofibromatosis Research Program (NFRP)
Exploration Hypothesis Development Award

Supports initial exploration of innovative, high-risk, high-gain concepts in NF research laying groundwork for future avenues of investigation. Preliminary or published data encouraged but not required.  Clinical trials not allowed. 
Amount & Project Period: $100,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
PA Link: W81XWH-14-NFRP-EHDA

Neurofibromatosis Research Program (NFRP)
Clinical Trial Award

The CTA funds Phase 0, I, or II clinical trials relevant to NF and/or schwannomatosis. Combinations of phases are permitted. Scientific rationale and/or preliminary data are required for pilot trials and for Phase I, II trials.
Amount & Project Period: $900,000 (Direct Costs) - 4 years
Eligibility: Established Investigators (Independent at or above Assistant Professor)
Contact: Linda Nolan (x6071)
PA Link: W81XWH-14-NFRP-CTA


New
July 15 All Faculty Ranks Internal Funding Clinical Trials

Moffitt Clinical Trial Funding Opportunity - Cycle II

Emphasis on increasing minority accrual and utilization of Total Cancer Care.  Funding will be awarded to a proposal for an investigator-initiated phase 0, I, or II therapeutic or supportive care clinical trial that addresses an underrepresented population and is likely to lead to increased minority subject accrual.
Due Date July 15 (as a PDF file to Maureen Ahearn (x8824)
Amount & Project Period: $100,000 for the clinical trial (including trial coordination, data management, non-billable lab tests, etc.) and up to $50,000 for correlative science costs (including shared resources, research lab supplies and tech support).
Eligibility: All Faculty Ranks
Contact: Maureen Ahearn (x8824)
RFA Link: RFP Clinical Trial Funding Opportunity


New
Jul. 23 (Pre-app.) Established Investigators Federal Biospecimen Resource Site

Prostate Cancer Research Program Prostate Cancer Biospecimen Resource Site Award

to expand the PCBN by adding Resource Sites that will enhance the biorepository's utility to prostate cancer researchers through the provision of biospecimens that are unique and/or in limited supply.
Due Date July 23 (Pre-application)
Invited Submissions
October 27 (OSR)   |  October 29 (Sponsor)
Amount & Project Period: $200,000/year (Direct Costs) - 2 years
Eligibility: Established Investigators
Contact: Linda Nolan (X6071)
PA Link: W81XWH-14-PCRP-PCBRSA
New
Jul 23 (Pre-app.) Established Investigators Federal Pre-clinical Studies

Prostate Cancer Research Program
Laboratory - Clinical Transition Award

Supports product-driven preclinical studies of promising lead agents or medical devices that have the potential to revolutionize prostate cancer clinical care.
 
Due Dates: July 23 (pre-application)
Invited Submissions:
October 27 (OSR)  |    October 29 (Sponsor)
Amount & Project Period: $500,000/year (Direct Costs) - 3 years
Eligibility: Established Investigators
Contact: Linda Nolan (x6071)
PA Link: W81XWH-14-PCRP-LCTA
New
Jul. 23 (Pre-app) All Faculty Federal Health Disparities

Prostate Cancer Research Program
Dr. Barbara Terry-Koroma Health Disparity Research Award

Supports new ideas based on innovative concepts or methodologies for health disparity research with the potential to make an important contribution toward eliminating death from prostate cancer and enhancing the well-being of men impacted by the disease. Applicants for this award must explicitly state how the proposed research is related to an area of prostate cancer health disparity.
 
Due Date July 23 (Pre-application)
Invited Submissions:
September 22 (OSR)  |  September 24 (Sponsor)
Amount & Project Period: $350,000 (Direct Costs) - 3 years (New & Established Investigators
$600,000 (Direct Costs - 3 years (If using Qualified Collaborator Option)
Additional $92,500 (if using Nested Health Disparity Traineeship Option for Pre-doctoral trainee)
Additional $115,000 (if using Nested Health Disparity Traineeship Option for postdoctoral trainee)
Eligibility: All Faculty
Contact: Linda Nolan (X6071)
RFA Link: W81XWH-14-PCRP-HDRA
New
Jul. 23 (Pre-app.) All Faculty Federal Prostate (Clinical)

Prostate Cancer Research Program Clinical Exploration Award

Supports clinical trials encompassing Phase 0, Phase I, or pilot Phase II for drugs or drug combinations, Class II or III for devices, or other types of trials conducting early clinical testing of innovative approaches for prostate cancer.  Also supports innovative, hypothesis-based, correlative studies that derive from ongoing or completed clinical trials supported by other funding sources.
Due Date July 23 (Pre-application)
Invited Submissions
: October 27 (OSR)  |  October 29 (Sponsor)
Amount & Project Period: $450,000 (Direct Costs) - 5 years
Eligibility: All Faculty
Contact: Linda Nolan (x6071)
PA Link: W81XWH-14-PCRP-CEA


Jul. 28 Postdocs Non-Federal Career Development

Stand Up To Cancer-Cancer Research UK Translational Research Fellowship

Translational research addressing critical problems in cancers with potential to deliver patient benefit.

Due Date July 24 - (OSR) | July 28 - (Sponsor)
Amount & Project Period: $315,000 total costs for 4 years
Eligibility: Open to US and UK-based individuals holding a PhD and/or a US medical degree and have less than 2 years of postdoctoral or clinical research experience.   Must identify 1 qualified US host laboratory and mentor,  and 1 qualified UK host laboratory and mentor. Work must be performed in 2 phases: 1 in the United States and 1 in the United Kingdom.
Contact: Linda Nolan, x6071
RFA Link: SU2C Funding Opportunities - AACR

Cancer Research UK Program

Guidelines
T32 NIH
June 24 (LOI)
July 24 (OSR)
July 28 (Sponsor)
Established
Faculty
Federal Big Science Training

Pre-doctoral Training in Biomedical Big Data Science

This pre-doctoral training initiative:
1. Requires trainees to work effectively at the intersection of computer science/informatics, statistics/mathematics, and biomedical science;
2. Expects active participation of training faculty from all 3 of these scientific disciplines working collaboratively as co-mentors of trainees in Big Data Science; and
3. Develops skills required to participate in a team approach to solving data-intensive biomedical problems.

Due Date

June 24 - Letter of Intent
Applications Due:
July 24 (OSR) | July 28 (Sponsor)
Amount & Project Period: Approximately $350,000 total costs over 5 year.
Eligibility: Established Investigators in areas relevant to biomedical Big Science Data.
Contact: Linda Nolan, x6071
RFA Link: RFA-HG-14-004
R01 NIMHD

New
Jul 28 (LOI) All Ranks Federal Health Disparities

Basic and Applied Biomedical Research on Minority Health and Health Disparities (R01)

Basic and applied research on fundamental biological mechanisms involved in disease conditions that disproportionately affect health disparity populations and therapies, or interventions that can directly or demonstrably contribute to reducing or eliminating health disparities.
Due Date July 28 (Letter of Intent)
Applications Due:
August 26 (OSR)  |  August 28 (Sponsor)
Amount & Project Period: $250,000 (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (X6071)
RFA Link: RFA-MD-14-005


Lung Cancer
Research
Program (LCRP)
New
Jul. 29 (Pre-app.) All Ranks Federal Lung

LCRP - Concept Award

The Concept Award supports highly innovative, untested, potentially groundbreaking concepts in lung cancer w/emphasis on innovation. Projects involving human subjects or human biological substances must be exempt or eligible for expedited review. Clinical trials not allowed. Preliminary data discouraged.
Due Date July 29 (Pre-application)
Applications Due:
August 08 (OSR)  |  August 12 (Sponsor)
Amount & Project Period: $100,000 (Direct Costs) -1 year
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link:  W81XWH-14-LCRP-CA
 

July 29 (OSR)
July 31 (Sponsor)
Clinical/Postdoctoral Fellows & Faculty Non-Federal Cutaneous Lymphoma

2014 CLARIONS Award Program - Curing Cutaneous Lymphoma by Advancing Research, Innovation and Offering New Solutions

 Innovative research in all areas of cutaneous lymphomas with particular interest in etiology and risk factors of cutaneous lymphomas, measures of disease impact on effected individuals and populations, translating discoveries into diagnostic and therapeutic advances,  optimizing therapies and improving quality of life for individuals with cutaneous lymphomas.
Due Date July 29 (OSR)  |  July 31 (Sponsor)
Amount & Project Period: $25,000 for 1 year
Eligibility: Investigators at all levels, from clinical and postdoctoral fellows to established investigators, are eligible to receive awards. Medical students and graduate students are not eligible.
Contact: Linda Nolan, x6071
Links: Research Awards Program

CLARIONS Application Manual

Grant Application


New
Jul. 30 (OSR)
Aug. 01 (Sponsor)
Postdocs/Fellows Non-federal Career Development/Neurology

Medical Education Research Training Fellowship

Priority given for plans evaluating educational outcomes impacting learning and medical practice change, population health outcomes, & patient quality or safety outcomes Intervention population may be medical students, residents, practicing physicians (i.e., CME), or inter-professional health care teams.
Due Date July 30 (OSR)  |  August 01 (Sponsor)
Amount & Project Period: $65,000 - 1 year

Eligibility: Must be an AAN member (Active or Junior) embarking on a career in medical education research who has completed a neurology, child neurology, or neuro-developmental disabilities residency or neurology fellowship w/in the past 5 years.

Contact: Linda Nolan (x6071)

Links: Application Guidelines
AAN Overview
R01 NCI

New
Aug 03 All Faculty Federal Mouse Models

Collaborative Research Projects to Enhance Applicability of Mouse Models for Translational Research (Collaborative R01)

Applications sought from multi-disciplinary teams to expand, improve, or transform the utility of mouse cancer and tumor models for translational research.

For a linked set of collaborative R01s, each site has its own Program Director(s)/Principal Investigator(s), and the program provides a mechanism for cross-site coordination and communication.
Due Date: July 31 (OSR)  |  August 03 (Sponsor)
Amount & Project Period: $450,000/year (Direct Costs) - 3 years
Eligibility: All Faculty
Contact: Linda Nolan (X6071)
FOA Link: PAR-14-240
R01 NCI

New
Aug. 03 All Ranks Federal Mouse Models

Research Projects to Enhance Applicability of Mouse Models for Translational Research (R01)

Applications to support projects devoted to overcoming limitations of mouse and human-in-mouse oncology models,  defining a new translational use of models or mouse genetics for unmet needs, advancing standard practices for modeling human cancers and tumors in mice,  and for validating and credentialing models, or develop widely applicable tool strains or resources that enable cross-species comparisons.
Due Date: July 31 (OSR)  |  August 03 (Sponsor)
Amount & Project Period: $450,000/year (Direct Costs ) - 3 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-14-241
U24 NCI

New
Jul 02 (LOI)
Aug. 07 (Sponsor)
All Faculty Federal Mouse Models

Oncology Models Forum

To establish and maintain an "Oncology Models Forum" Focus is anticipated to be on effective, reliable use of mice, mouse models, and human-in-mouse models in translational cancer research, and other mouse modeling needs that the scientific community identifies.
Due Date: July 02 (letter of Intent)
Applications Due:
August 05 (OSR)  |  August 07 (Sponsor)
Amount & Project Period: $750,000/year (Direct Costs) - 5 years
Eligibility: All Faculty
Contact: Linda Nolan (X6071)
FOA Link: PAR-14-239


New
Aug. 11 (OSR)
Aug. 13 (Sponsor)
Postdocs/Jr. Faculty Non-federal Lung Cancer

Uniting Against Lung Cancer (UALC) - Legacy Program

Seed money for promising and potentially transformative new projects. Interdisciplinary collaborations strongly encouraged. Does not require large amounts of preliminary data, but must have a clear hypothesis and research plan.
Due Date: August 11 (OSR)  |  August 13 (Sponsor)
Amount & Project Period: $50,000/year (Incl. 10% F&A) - 2 years
Eligibility: Hold a faculty appointment or be mentored by a faculty member
Contact: Linda Nolan (x6071)
RFA Links: Legacy Program  (Guidelines)
Uniting Against Lung Cancer (Funding Page)

New
Aug. 11 Asst/Assoc members Internal Funding Career Development

Moffitt Medical Group (MMG) Junior Faculty Team Research Award - Cycle I

Promotes exploration of innovative ideas and establishment of new collaborations.
It is intended that the MMG Junior Faculty Team Research Award will be used for research directly related to cancer investigation and must be translational or clinical in nature.  May request support for a clinical trial already been written; if so, a draft protocol and informed consent must be enclosed with application. MMG Junior Faculty Team Research Award may be awarded to investigators working with animal models, or to investigators using human tissue, fluid or blood samples for pre-clinical studies.
Due Date August 11 (Submitted as a single PDF file to Kim Murphy by 4:00pm)
Amount & Project Period: $20,000 to $50,000 - 1 year
Eligibility: Investigator must have completed the M.D. or PhD., be a member of the Moffitt Medical Group (MMG), and must have a track record of productivity.  Those new to cancer research will receive priority.
Contact: Kim Murphy (x1432)
RFA Link: MMG Jr. Faculty Team Research Guidelines | Application


Cycle 2
Aug. 13 (OSR)
Aug. 15 (Sponsor)
Postdocs/Fellows Non-federal Career Development

Damon Runyon Fellowship Award

Supports all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention
Due Date: August 13 (OSR)  |  August 15 (Sponsor)
Amount & Project Period: 3-year period
Level 1: Stipend: $50,000/yr. Allowance: $2,000/yr
Level 2: Stipend: $60,000/yr. Allowance: $2,000/yr.
Eligibility: Level 1 Funding: Basic and physician-scientist – degree received
< 1 year prior to the Fellowship Award Committee (FAC) meeting when application is considered, and not have been in Sponsor's lab >1 year prior to meeting.
Level 2 Funding: Physician-scientist applicant - (MD, MD/PhD, DDS, DVM or equiv.) must have completed residency & clinical training and be board-eligible in U.S. at award. Postdoctoral fellows, clinical fellows and clinical instructors are eligible. Foreign candidates may apply to do research only in U.S.
Contact: Linda Nolan (X6071)
Link: Fellowship Application Guidelines
August 1 (Pre-app)
August 13 (OSR)
August 15 (Sponsor)
Jr. Faculty Federal Breast Cancer 

Breast Cancer Research Program (BCRP) - Era of Hope Scholar Award

Central feature of the award is innovative contribution of Principal Investigator (PI) toward ending breast cancer.  PI should articulate a vision challenging current dogma and demonstrating ability to look beyond tradition and convention.
Due Date: August 1 (Pre-application)
Applications Due:
August 13 (OSR)  |  August 15 (Sponsor)
Amount & Project Period: $2,500,000 direct costs for 5 years.
Eligibility: Jr. Faculty: Independent investigator within 6 years of last training position.
Contact: Linda Nolan, x6071
PA Link: W81XWH-14-BCRP-EOHS
August 11 (LOI)
Sept. 7 (OSR)
Sept 11 (Sponsor)
All Faculty Federal Radiation Dosing

Decreasing Patient Radiation Dose from CT Imaging: Achieving Sub-mSv Studies

 Research leading to reduction of patient radiation exposure from a routine CT scan to exposures <1 mSv.
Due Date: August 11 (Letter of Intent)
Applications Due:

September 07 (OSR)  |  September 11 (Sponsor)
Amount & Project Period: Unlimited budget for 4 years
Eligibility: All Faculty
Contact: Linda Nolan, x6071
FOA Link: PAR-12-206
August 13 (OSR)
August 15 (Sponsor)
All Ranks Non-Federal Pancreatic Cancer

Hershberg Foundation for Pancreatic Cancer Research - Seed Grants

To provide start-up funding to test innovative ideas for improving diagnosis and to develop new treatment modalities in pancreatic cancer; obtain preliminary data required for additional funding impact on the understanding of pancreatic cancer cell biology, biochemistry, physiology, morphology and response to therapy and to establish collaborations within the field.
Due Date: August 13 (OSR)  |  August 15 (Sponsor)
Amount & Project Period: $50,000 for 1 year (Renewable)
Eligibility: All Ranks
Contact: Linda Nolan, x6071
RFA Link: Seed Grants


New
Aug. 27 (Pre-app.) Postdocs Federal Career Development

Prostate Cancer Research Program Postdoctoral Training Award

Supports prostate cancer research training opportunities for recent doctoral graduates.

Due Date August 27 (Pre-application)
Applications Due:
September 08 (OSR)  |  September 10 (Sponsor)
Amount & Project Period: $57,500/year (Direct Costs) - 2 years
Eligibility: Postdocs
Contact: Linda Nolan (x6071)
PA Link: W81XWH-14-PCRP-PTA
New
Aug. 27 (Pre-app.) Clinical fellows/Jr. Faculty Federal Career Development

Prostate Cancer Research Program Physician Research Training Award

Supports a mentored training experience to prepare physicians with clinical duties and/or responsibilities for productive careers in prostate cancer research. Emphasizes equally the quality of both the research and the training proposed.
Due Date August 27 (Pre-application)
Applications Due:
September 08 (OSR)  |  September 10 (Sponsor)
Amount & Project Period: $130,000/year (Direct Costs) - 4 years
Eligibility: Must be a physician with clinical duties and/or responsibilities. 
Must be in last year as resident/fellow or w/in 3 years of Jr. Faculty appt.
Contact: Linda Nolan (x6071)
PA Link: W81XWH-14-PCRP-PRTA


New
Aug. 27 (OSR)
Aug. 29 (Sponsor)
Established Investigators Non-federal Gastric Cancer

R. Robert & Sally Funderburg Research Award in Gastric Cancer

Novel approaches in gastric cancer research, including:  gastric mucosal cell biology; regeneration and regulation of cell growth (not as related to peptic ulcer disease or repair); inflammation (including Helicobacter pylori) as precancerous lesions; genetics of gastric carcinoma; oncogenes in gastric epithelial malignancies; epidemiology of gastric cancer; etiology of gastric epithelial malignancies; or clinical research in diagnosis or treatment of gastric carcinoma.
Due Date August 27 (OSR)  |  August 29 (Sponsor)
Amount & Project Period: $50,000/year - 2 years
Eligibility: Established Investigator in Gastric Biology
AGA membership required at time of submission
Contact: Linda Nolan, x6071
RFA Link: Research Award in Gastric Cancer


New
Sept. 11 (OSR)
Sept. 15 (Sponsor)
Postdocs Non-federal Career Development

Sloan Research Fellowships

To stimulate fundamental research by early-career scientists and scholars of outstanding promise   A program designed to stimulate fundamental research by early career scientists and scholars of outstanding promise.
Due Date September 11 (OSR)  |  September 15 (Sponsor)
Amount & Project Period: $50,000 - 2 years
Eligibility:
  • Must hold a tenure track (or equivalent) position at a college, university, or other degree-granting institution.
  • Tenure track faculty positions at the candidate's institution must include a yearly teaching requirement.
  • Candidates must hold a Ph.D. (or equivalent) in chemistry, computational or evolutionary molecular biology, computer science, economics, mathematics, neuroscience, ocean sciences, physics, or a related field;
  • Candidates' most recent Ph.D. (or equivalent) must have been awarded on or after September 1, 2008.
  • Exceptions may apply.
Contact: Linda Nolan (x6071)
RFA Link: Sloan Research Fellowships


New
Sept 30 All Faculty Non-federal Scientific Achievement

National Foundation for Cancer Research (NFCR)
2015 Szent-Györgyi Prize

Annual prize, in honor of Albert Szent-Györgyi, Nobel Laureate and co-founder of NFCR, awarded to an outstanding researcher whose scientific achievements have expanded understanding of cancer and whose discoveries have made possible new approaches to preventing, diagnosing, and/or treating cancer. 
Due Date Nominations Due:  September 30
Amount & Project Period: $25,000 cash prize and recipient will lead the next Szent-Györgyi prize committee as honorary chair.
Eligibility: Candidates must have made an original discovery or breakthrough in scientific understanding that has led to better prevention, earlier diagnosis, or new treatments for patients with cancer.
Contact: Linda Nolan (x6071)
Links: 2015 Szent-Györgyi Prize Nominations
Call for Nominations
National Foundation for Cancer Research


Cycle 2
Sept. 29 (OSR) 
Oct. 01 (Sponsor)
Postdocs Non-federal Immunology Career Development

Irvington Post Doctoral Fellowships

Provides critical financial support and continued career training in cancer immunology
 
Due Date September 29 (OSR)  |  October 01 (Sponsor)
Amount & Project Period: 3 years - Stipend of
$50,000 Year 01
$53,000 Year 02
$57,000 Year 03 and
$1,500/year for research support
Eligibility: Must have doctoral degree by date of award activation. Applicants with 5 or more years of relevant postdoctoral experience are not eligible, with the exception of MD applicants, who should not include years of residency in this calculation.
Contact: Linda Nolan (X6071)
RFA Link: Irvington Post Doctoral Fellowships

Elsa U. Pardee Foundation

New
Sept. 29 (OSR)
Oct. 01 (Sponsor)
All Ranks Non-federal Career Development

Elsa U. Pardee Foundation Research Grants

Research directed toward identifying new treatments or cures for cancer, particularly encouraging applications for a one year period which will allow establishment of capabilities of new cancer researchers, or new cancer approaches by established cancer researchers.
Due Date September 29 (OSR)  |  October 01 (Sponsor)
Amount & Project Period: Budgets are not limited - 1 year
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: Elsa U. Pardee Research Grants


New
Oct 13 (OSR)
Oct 15 (Sponsor)
PIs w/eligible grants Federal Dietary Supplements

Research on Dietary Supplements (Admin. Supplement)

To support research where supplemental funding would investigate the role of dietary supplements and/or their ingredients in health maintenance and disease prevention. Parent awards need not be focused on dietary supplements.

Due Date October 13 (OSR)  |  October 15 (Sponsor)
Amount & Project Period: $100,000 (Total Costs) - Project and budget periods must be w/in currently approved project period for existing parent award
Eligibility: All PIs w/eligible awards (see FOA) - For parent awards that include multiple PDs/PIs, supplement may be requested by any or all of the PDs/PIs (in accordance w/existing leadership plan)
Contact: Linda Nolan (X6071)
FOA Link: PAR-14-201
Toolbox
Funding Opportunities

Funding Opportunity Calendar
OSR's Grant News
grants.gov
NCI Funding Opportunities
NIH Guide to Grants & Contracts

RaceTracks

Federal Opportunities
Moffitt-Sponsored (Intramural) Opportunities
Opportunities Focused on Thoracic Oncology
Grant Preparation

Proposal Submission Form
Grants.gov Instructions
PHS398 Instructions
NIH 2590 Instructions
Other

PubMed
National Cancer Institute

Clinical Research

Who To Call in Clinical Research
Clinical Research FAQs
Data Safety Monitoring Plan
USF IRB
Liberty IRB
Questions?
MRISignals@moffitt.org